Progress of Neoadjuvant Therapy Combined with Surgery in Non-small Cell Lung Cancer
Background and objective Lung cancer is the leading form of cancer in terms of both incidence and cancer-related Razors deaths.For patients with resectable IIIa/N2 non-small cell lung cancer (NSCLC), guidelines in and abroad recommend multidisciplinary team treatment, including surgery and chemotherapy, radiotherapy or other comprehensive treatment